The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGRA.L Regulatory News (GRA)

  • There is currently no data for GRA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-close statement and Trading Update

3 May 2023 07:00

RNS Number : 1872Y
Grafenia plc
03 May 2023
 

 

Prior to publication, the information contained within this announcement was deemed by the Company to constitute inside information as stipulated under the UK Market Abuse Regulation. With the publication of this announcement, this information is now considered to be in the public domain.

 

3 May 2023

 

Grafenia plc

("Grafenia" or "the Company" or the "Group")

 

Pre-close statement and Trading Update

 

Grafenia plc (AIM: GRA) announces the following pre close statement and trading update for the year ended 31 March 2023 ("FY23").

 

Since releasing our half year results on 24 November 2022, we have continued to focus on and invest in building the structure required to become a serial acquirer of vertical market software businesses. Becoming the permanent home for those businesses and their management talent.

 

Today, the Group looks a little different. This time last year, we existed solely in the graphics space. We owned a manufacturing hub in Manchester (Works Manchester), business stores, superstores and online print platforms, and we licenced our software around the world.

 

Two things have changed since then. We no longer own Works Manchester and Grafenia no longer exists solely in the graphics space. We do still own business stores, superstores and online print platforms and we continue to drive recurring revenues and product sales by licensing our software around the world through our Nettl Systems business unit.

 

Following the sale of Works Manchester, as well as continuing our push for organic growth, we have doubled down on our acquisition strategy with the aim of creating long term growth in shareholder value. Focussing on vertical market software businesses, we look for niche platforms, with low churn where the majority of sales are recurring in nature. Through our specialist M&A team, Software Circle, we've built a healthy deal flow and successfully acquired four software businesses that have met our criteria.

 

Grafenia is now home to a stable of five software business units across multiple sectors. In terms of sales, Nettl Systems currently remains the largest of those. Each business is run in a decentralised way by its own management team, supported by the Grafenia Board. Those businesses have been, in the main, acquired during the latter stages of the FY23.

 

In that time, we have successfully onboarded our newly acquired businesses and they are contributing to profitability. On behalf of the Board, we welcome our new team members to the Grafenia family and thank all of our teams and owners across the Group for making that onboarding a success.

  

 

Our Current Portfolio:

 

BusinessUnit

Sector

DateAcquired

InitialConsideration

Deferred

Consideration

Unaudited Group SalesFY23

Nettl Systems

Graphics & Ecommerce

n/a

n/a

n/a

£9.5m

Vertical Plus

Ecommerce

01/10/22

£1.25m

£1.0m

£1.0m

Watermark

Document Management

07/12/22

£1.50m

£1.0m

£0.4m

CareDocs

Care Management

18/01/23

£2.98m

£0.52m

£0.5m

TopFloor

Property Management

17/02/23

£3.42m

£0.85m

£0.2m

Total

£9.15m

£3.37m

£11.6m

 

We've grown again on the previous year. We expect to end the full year with sales from continuing operations in excess of £11.6m (2022: £8.2m). An increase of £3.4m (41%).

 

Approximately £9.5m (2022: £8.2m) of total sales, came from our Nettl Systems business. A 16% organic increase of £1.3m.

 

£2.1m of total sales was generated by the four acquisitions acquired during the latter stages of FY23 as detailed in the above table. A 26% growth in sales by acquisition.

 

Sales from discontinued operations were approximately £0.9m (2022: £3.4m).

 

We expect our operating businesses to generate a positive EBITDA of £0.4m after central costs of £0.8m. Deducting the associated non-recurring deal costs involved in the acquisitions, the EBITDA overall is £0.1m (2022 £0.3m).

 

With the acquisitions we've added to the Group, on a run rate basis, annualised sales would be approximately £17m. We are currently considering raising additional funds to continue the execution of our acquisition strategy and the growth of the Group.

 

Cash at 31 March 2023 was £2.0m (2022: £1.5m). During the year we utilised our bond facility issuing £11.2m of Bonds, at nominal value, raising £9.5m before expenses. We deployed £9.6m of capital. Net debt as at 31 March 2023 was £16.3m (2022: £5.3m).

 

Leadership Team

Gavin Cockerill has successfully led the Group's repositioning as Acting CEO over the last 12 months. After an extensive board review, we are very pleased to announce that Gavin will lead the Group as CEO going forward.

Jan-Hendrik Mohr, Chairman of Grafenia, said:

"The board is very pleased with Gavin's leadership over the last year. We started with the idea of becoming the right home for vertical market software companies in the UK and Ireland. Gavin has combined the existing strengths of our rich legacy in Nettl Systems and applied that to our growing group of software companies."

 

Outlook

We're cautiously optimistic about the upcoming year. With a full year's trade from our newly acquired businesses, our goal of achieving EBITDA at 10-15% of sales, after central costs, is a realistic target. Our search for software businesses continues and our deal flow looks healthy. We will update the market with more detailed progress when releasing our final results for FY23 which is expected to be at the end of July.

 

For further information:

Grafenia plc

Gavin Cockerill (CEO) 07968 510 662

 

Allenby Capital Limited (Nominated Adviser and Broker)

David Hart / Piers Shimwell (Corporate Finance) 0203 328 5656

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTATMPTMTAMBLJ
Date   Source Headline
17th Oct 20237:00 amRNSChange of Company name effective
16th Oct 20236:30 pmRNSDirector/PDMR Shareholding
6th Oct 20239:37 amRNSGrant of options
26th Sep 202312:21 pmRNSResult of AGM and Change of Name and Website
21st Sep 20237:00 amRNSHolding(s) in Company
20th Sep 20235:39 pmRNSHolding(s) in Company
15th Sep 20235:47 pmRNSReplacement: Result of GM and Open Offer
15th Sep 202310:22 amRNSResult of General Meeting and Open Offer
8th Sep 20232:03 pmRNSDirector/PDMR Shareholding
29th Aug 20237:00 amRNSFundraise of up to £27.9 million and other matters
26th Jul 20237:00 amRNSFinal Results
1st Jun 20237:00 amRNSUpdate re. the sale of Works Manchester Limited
3rd May 20237:00 amRNSPre-close statement and Trading Update
3rd Apr 20231:13 pmRNSHolding(s) in Company
17th Feb 202312:35 pmRNSAcquisition of Topfloor Systems Limited
20th Jan 20232:49 pmRNSBond Issue
18th Jan 20237:00 amRNSAcquisition of Care Management Systems Limited
28th Dec 20227:00 amRNSHolding(s) in Company
13th Dec 20227:00 amRNSReplacement: Bond Issue
12th Dec 20225:51 pmRNSBond Issue
7th Dec 20225:07 pmRNSAcquisition of Watermark Technologies Limited
24th Nov 20227:00 amRNSHalf-year Report
31st Oct 20227:00 amRNSBoard Appointment
7th Oct 202211:37 amRNSHolding(s) in Company
6th Oct 20221:48 pmRNSHolding(s) in Company
27th Sep 202212:56 pmRNSBond Issue
22nd Sep 20224:09 pmRNSAcquisition of Vertical Plus Limited
14th Sep 20222:18 pmRNSResult of AGM
27th Jul 20223:18 pmRNSReplacement: Final Results
27th Jul 20227:00 amRNSFinal Results
19th May 20227:00 amRNSSale of Subsidiary and Board Changes
4th May 20229:01 amRNSDirector/PDMR Shareholding
6th Apr 202212:00 pmRNSPre-close statement and Trading Update
22nd Nov 20217:00 amRNSHalf-year Report
15th Sep 202110:35 amRNSResult of AGM
15th Sep 20217:00 amRNSAGM Trading Statement
28th Jul 20217:00 amRNSFinal Results
16th Apr 20217:00 amRNSPre-close Trading and Strategy Update
3rd Mar 20217:00 amRNSBlock admission review & block cancellation
8th Jan 202112:38 pmRNSStmnt re Share Price Movement
31st Dec 20201:00 pmRNSTotal Voting Rights
14th Dec 20203:45 pmRNSIssue of Equity re Share Stake Scheme
25th Nov 20207:00 amRNSHalf-year Report
22nd Sep 202011:31 amRNSResult of AGM
22nd Sep 20207:00 amRNSAGM Trading Statement and Acquisition Update
3rd Sep 20207:00 amRNSBlock listing Interim Review
1st Sep 20207:00 amRNSReplacement: Final Results
12th Aug 20207:00 amRNSFinal Results
24th Jul 202012:37 pmRNSReplacement: Bond Facility & trading update
15th Jul 202010:45 amRNSBond Facility for up to £50m & trading update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.